The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

Camille C.B. Kockerols; Inge Geelen; Mark David Levin; Jeroen J.W.M. Janssen; Avinash G. Dinmohamed; Mels Hoogendoorn; Jan J. Cornelissen; Peter E. Westerweel

doi:10.3324/haematol.2021.280501

The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

Camille C.B. Kockerols^*
, Inge Geelen
, Mark David Levin
, Jeroen J.W.M. Janssen
, Avinash G. Dinmohamed
, Mels Hoogendoorn
, Jan J. Cornelissen
, Peter E. Westerweel

^*Corresponding author for this work

Amsterdam UMC
Medical Centre Leeuwarden

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

11 Citations (Scopus)

46 Downloads (Pure)

Original language	English
Pages (from-to)	1940-1943
Number of pages	4
Journal	Haematologica
Volume	107
Issue number	8
DOIs	https://doi.org/10.3324/haematol.2021.280501
Publication status	Published - Aug 2022

Bibliographical note

Funding Information:
The Pharos-CML database was financially supported by grants from Novartis and BMS to the Netherlands Comprehensive Cancer Organisation (IKNL). The authors have no other conflicts of interest to disclose.

Access to Document

10.3324/haematol.2021.280501Licence: CC BY-NC

10594-Article Text-77914-2-10-20220728Final published version, 343 KBLicence: CC BY-NC

Cite this

@article{4c714c7b16924d03969b7bb10267d778,

title = "The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era",

author = "Kockerols, \{Camille C.B.\} and Inge Geelen and Levin, \{Mark David\} and Janssen, \{Jeroen J.W.M.\} and Dinmohamed, \{Avinash G.\} and Mels Hoogendoorn and Cornelissen, \{Jan J.\} and Westerweel, \{Peter E.\}",

note = "Funding Information: The Pharos-CML database was financially supported by grants from Novartis and BMS to the Netherlands Comprehensive Cancer Organisation (IKNL). The authors have no other conflicts of interest to disclose.",

year = "2022",

month = aug,

doi = "10.3324/haematol.2021.280501",

language = "English",

volume = "107",

pages = "1940--1943",

number = "8",

}

TY - JOUR

T1 - The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

AU - Kockerols, Camille C.B.

AU - Geelen, Inge

AU - Levin, Mark David

AU - Janssen, Jeroen J.W.M.

AU - Dinmohamed, Avinash G.

AU - Hoogendoorn, Mels

AU - Cornelissen, Jan J.

AU - Westerweel, Peter E.

N1 - Funding Information: The Pharos-CML database was financially supported by grants from Novartis and BMS to the Netherlands Comprehensive Cancer Organisation (IKNL). The authors have no other conflicts of interest to disclose.

PY - 2022/8

Y1 - 2022/8

UR - https://www.scopus.com/pages/publications/85135421360

U2 - 10.3324/haematol.2021.280501

DO - 10.3324/haematol.2021.280501

M3 - Comment/Letter to the editor

C2 - 35354254

AN - SCOPUS:85135421360

SN - 0390-6078

VL - 107

SP - 1940

EP - 1943

JO - Haematologica

JF - Haematologica

IS - 8

ER -

The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era

Bibliographical note

Access to Document

Other files and links

Cite this